Bibliographic Details
| Title: |
948 Final results from AIPAC: A phase IIb comparing eftilagimod alpha (a soluble LAG-3 protein) vs. placebo in combination with weekly paclitaxel in HR+ HER2- MBC |
| Authors: |
Christian Mueller, Frederik Marmé, Luc Dirix, Frederic Triebel, Hans Wildiers, Peter Vuylsteke, Chrystelle Brignone, Jens Huober, Sherko Kümmel, Anne Armstrong, Eveline De Cuypere, Florence Dalenc, Steven Chan, Carolina Pia Schröder, Jean-Philippe Jacquin, Etienne Brain, Zsuzsanna Pápai |
| Source: |
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021) |
| Publisher Information: |
BMJ Publishing Group, 2021. |
| Publication Year: |
2021 |
| Collection: |
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| Subject Terms: |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
2051-1426 |
| Relation: |
https://doaj.org/toc/2051-1426 |
| DOI: |
10.1136/jitc-2021-SITC2021.948 |
| Access URL: |
https://doaj.org/article/00ecb4048bde480ea77f378c88831f49 |
| Accession Number: |
edsdoj.00ecb4048bde480ea77f378c88831f49 |
| Database: |
Directory of Open Access Journals |
